CASP3 and osteosarcoma: MG132 (a proteosomal inhibitor) simultaneously promoted the expression of the proapoptotic protein Noxa and the nuclear translocation of β-catenin in the Saos2 osteosarcoma cell line through a p53-independent pathway, favoring caspase-3 activation [170].